Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Jukema

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
Heart (British Cardiac Society)|September 25, 2012
Late acquired stent malapposition: why, when and how to handle?Ioannis Karalis, Tarek A H N Ahmed, J W Jukema
Nederlands Tijdschrift Voor Geneeskunde|December 29, 2007
[The endocannabinoid system, overweight, and the CB1-endocannabinoid-receptor antagonist rimonabant]S M Boekholdt, J W Jukema, R J G Peters
Indian Heart Journal|July 1, 1993
Progression and regression of coronary atherosclerosisA V Bruschke, J W Jukema, E E Van der Wall
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 11, 2012
Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the NetherlandsD Liew, K Webb, W-J Meerding, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart diseaseJ S Rana, M Nieuwdorp, J W Jukema, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Do patients benefit from drug-eluting stents in acute myocardial infarction?R F R Steens, J W Jukema, E E van der Wall
European Heart Journal|November 1, 2001
Genetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapyW R Agema, J W Jukema, S N Pimstone, et al.
Frontiers in Cardiovascular Medicine|November 1, 2023
High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicineE Reijnders, A van der Laarse, J W Jukema, et al.
Clinical Genetics|October 10, 2017
Response to Ciuculete et alR A J Smit, S le Cessie, J W Jukema, et al.
American Heart Journal|November 1, 1992
Pseudoaneurysm of a saphenous vein coronary artery bypass graft with a fistula draining into the right atriumJ W Jukema, P R van Dijkman, E E van der Wall
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Heart (British Cardiac Society)|September 25, 2012
Late acquired stent malapposition: why, when and how to handle?Ioannis Karalis, Tarek A H N Ahmed, J W Jukema
Nederlands Tijdschrift Voor Geneeskunde|December 29, 2007
[The endocannabinoid system, overweight, and the CB1-endocannabinoid-receptor antagonist rimonabant]S M Boekholdt, J W Jukema, R J G Peters
Indian Heart Journal|July 1, 1993
Progression and regression of coronary atherosclerosisA V Bruschke, J W Jukema, E E Van der Wall
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 11, 2012
Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the NetherlandsD Liew, K Webb, W-J Meerding, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart diseaseJ S Rana, M Nieuwdorp, J W Jukema, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Do patients benefit from drug-eluting stents in acute myocardial infarction?R F R Steens, J W Jukema, E E van der Wall
European Heart Journal|November 1, 2001
Genetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapyW R Agema, J W Jukema, S N Pimstone, et al.
Frontiers in Cardiovascular Medicine|November 1, 2023
High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicineE Reijnders, A van der Laarse, J W Jukema, et al.
Clinical Genetics|October 10, 2017
Response to Ciuculete et alR A J Smit, S le Cessie, J W Jukema, et al.
American Heart Journal|November 1, 1992
Pseudoaneurysm of a saphenous vein coronary artery bypass graft with a fistula draining into the right atriumJ W Jukema, P R van Dijkman, E E van der Wall
Pageof 23